LNTH earnings: real EPS beat/miss history, analyst consensus Buy, P/E 24.85. Updated 2026-07-23.
Lantheus Holdings (LNTH) Research Hub
Lantheus Holdings (LNTH) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 100.25 USD (-0.45%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 24.85, market cap 6.87B. This hub links to the full technical, earnings and options research available for LNTH.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 100.25 USD (-0.45%) |
| 52-week range | 98.81 USD – 111.86 USD |
| Trend regime | Range |
| 14-day RSI | 41.2 (Bearish) |
| Trailing P/E | 24.85 |
| Market cap | 6.87B |
| Dividend yield | 0.00% |
Available research for LNTH
Covered Call on LNTH: how it works, illustrative setup around the real 100.25 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LNTH: how it works, illustrative setup around the real 100.25 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LNTH: how it works, illustrative setup around the real 100.25 USD price, max profit/loss, breakeven and when to use it. Educational.
LNTH technical analysis: range, last 100.25 USD, RSI 41.2, 52w range 98.81 USD–111.86 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LNTH in?
Lantheus Holdings (LNTH) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is LNTH in an uptrend or downtrend?
As of 2026-09-11, LNTH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LNTH's trailing P/E ratio?
LNTH's trailing P/E is 24.85, with a market cap of 6.87B. See the earnings research page for full valuation detail.